CN Stock MarketDetailed Quotes
300436 Fujian Cosunter Pharmaceutical
- 32.56
- -0.01-0.03%
Market Closed Dec 26 15:00 CST
5.19BMarket Cap-23.21P/E (TTM)
33.33High32.02Low56.73KlotVolume32.57Open32.57Pre Close186.13MTurnover4.15%Turnover RatioLossP/E (Static)159.27MShares37.9652wk High11.63P/B4.45BFloat Cap14.1652wk Low39.08Limit Up136.72MShs Float166.92Historical High26.06Limit Down4.02%Amplitude12.28Historical Low--Dividend TTM32.81Avg Price30.90KlotAsk--Div YieldTTM100Lot Size23.29KlotBid
Fujian Cosunter Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 16.67%326.32M | 22.93%218.18M | 36.06%120.05M | 9.58%422.71M | -5.98%279.69M | -7.80%177.49M | -8.59%88.23M | 4.14%385.77M | 9.74%297.47M | 11.07%192.5M |
| Operating revenue | 16.67%326.32M | 22.93%218.18M | 36.06%120.05M | 9.58%422.71M | -5.98%279.69M | -7.80%177.49M | -8.59%88.23M | 4.14%385.77M | 9.74%297.47M | 11.07%192.5M |
| Other operating revenue | ---- | -62.37%2.23M | ---- | 56.44%9.4M | ---- | -8.49%5.94M | ---- | 1,304.74%6.01M | ---- | 6,353.21%6.49M |
| Total operating cost | -9.88%405.41M | -15.58%264.17M | -16.84%135.82M | 5.88%657.28M | 0.85%449.86M | 13.37%312.94M | 25.94%163.31M | 36.71%620.78M | 35.57%446.06M | 29.85%276.03M |
| Operating cost | 9.16%126.87M | 13.04%84.6M | 30.25%48.43M | 13.40%180.05M | -6.89%116.22M | -6.81%74.84M | -10.25%37.18M | 14.76%158.77M | 21.79%124.82M | 26.82%80.31M |
| Operating tax surcharges | 5.97%6.94M | 4.04%4.56M | 5.62%2.23M | 0.86%8.8M | 0.53%6.55M | 1.79%4.39M | -6.54%2.11M | 27.36%8.73M | 28.57%6.51M | 30.95%4.31M |
| Operating expense | 10.75%144.48M | 6.87%90.87M | 4.55%43.83M | 7.10%189.79M | -1.20%130.46M | -0.51%85.03M | -1.76%41.92M | 4.37%177.21M | 6.86%132.05M | 9.17%85.46M |
| Administration expense | -4.36%78.78M | -5.65%52.81M | -10.36%25.47M | 34.51%114.92M | 37.97%82.37M | 44.07%55.97M | 67.75%28.41M | 31.61%85.44M | 23.94%59.71M | 14.16%38.85M |
| Financial expense | 15.86%25.49M | 23.26%16.97M | 34.75%8.66M | 494.32%30.75M | 679.98%22M | 924.18%13.77M | 1,071.80%6.43M | -0.69%5.17M | -44.92%2.82M | -69.90%1.34M |
| -Interest expense (Financial expense) | 3.39%26.6M | 8.86%17.89M | 19.22%9.16M | 230.70%35.03M | 248.09%25.73M | 253.61%16.44M | 253.75%7.69M | 16.07%10.59M | 2.93%7.39M | -5.18%4.65M |
| -Interest Income (Financial expense) | 70.86%-1.15M | 67.05%-944.3K | 64.32%-516.11K | 19.16%-4.5M | 15.71%-3.94M | 14.65%-2.87M | 12.32%-1.45M | -38.21%-5.56M | -119.46%-4.67M | -589.68%-3.36M |
| Research and development | -75.21%22.87M | -81.80%14.37M | -84.74%7.21M | -28.31%132.96M | -23.21%92.26M | 20.08%78.95M | 82.92%47.27M | 168.83%185.46M | 169.27%120.15M | 125.32%65.75M |
| Credit Impairment Loss | 144.16%196.16K | -77.21%77.32K | -128.81%-65.2K | -202.75%-1.77M | 135.74%80.34K | 260.40%339.24K | 1,766.41%226.28K | 23.09%-583.8K | 40.40%-224.8K | 32.70%94.13K |
| Asset Impairment Loss | 13.48%-4M | 47.26%-2.05M | 79.76%-538.06K | -45.04%-6.56M | -282.09%-4.62M | -556.33%-3.89M | -252,151.97%-2.66M | -144.82%-4.52M | ---1.21M | ---593.41K |
| Other net revenue | 169.34%11.02M | 198.96%11.88M | 113.69%788.78K | -181.54%-60.93M | -125.93%-15.89M | -125.38%-12.01M | -126.34%-5.76M | 90.73%74.73M | 94.21%61.29M | 157.94%47.3M |
| Invest income | 76.18%-3.99M | 83.07%-2.02M | 74.84%-1.65M | -187.69%-61.84M | -129.92%-16.77M | -127.39%-11.93M | -134.79%-6.54M | 164.35%70.52M | 155.99%56.03M | 317.65%43.54M |
| -Including: Investment income associates | 76.18%-3.99M | 83.07%-2.02M | 74.84%-1.65M | -188.19%-61.93M | -129.92%-16.77M | -127.39%-11.93M | -134.79%-6.54M | 163.23%70.22M | 155.99%56.03M | 317.65%43.54M |
| Asset deal income | ---- | ---- | ---- | ---19.05K | ---3.32K | --5.84K | --5.84K | ---- | ---- | ---- |
| Other revenue | 247.33%18.82M | 357.29%15.88M | -5.30%3.04M | -0.57%9.26M | -19.11%5.42M | -18.50%3.47M | 5.35%3.21M | -39.62%9.31M | -35.46%6.7M | -47.85%4.26M |
| Operating profit | 63.41%-68.08M | 76.87%-34.11M | 81.47%-14.98M | -84.35%-295.49M | -113.12%-186.06M | -307.15%-147.46M | -616.43%-80.84M | -260.34%-160.29M | -230.47%-87.3M | -73.10%-36.22M |
| Add:Non operating Income | -73.28%90.34K | -93.49%16.38K | 32.92%63.95K | 688.68%975.34K | 169.31%338.11K | 174.32%251.8K | 49.26%48.11K | -59.88%123.67K | -13.68%125.55K | -39.12%91.79K |
| Less:Non operating expense | -7.11%1.8M | -91.23%96.35K | 99.80%52.9K | 7.96%3.51M | 31.27%1.94M | 490.66%1.1M | -76.20%26.48K | 114.53%3.25M | 317.59%1.48M | 127.88%186.08K |
| Total profit | 62.81%-69.79M | 76.95%-34.19M | 81.48%-14.97M | -82.37%-298.03M | -111.67%-187.66M | -308.42%-148.31M | -611.26%-80.82M | -257.66%-163.42M | -232.97%-88.66M | -74.13%-36.31M |
| Less:Income tax cost | -83.61%3.97M | -91.60%1.93M | 97.42%-264.84K | 436.35%76.87M | 444.82%24.2M | 580.40%22.97M | -3,594.74%-10.26M | -98.27%-22.86M | 2.48%-7.02M | -6.15%-4.78M |
| Net profit | 65.19%-73.76M | 78.91%-36.12M | 79.16%-14.71M | -166.71%-374.9M | -159.52%-211.86M | -443.19%-171.27M | -536.53%-70.56M | -311.45%-140.57M | -320.18%-81.64M | -92.85%-31.53M |
| Net profit from continuing operation | 65.19%-73.76M | 78.91%-36.12M | 79.16%-14.71M | -166.71%-374.9M | -159.52%-211.86M | -443.19%-171.27M | -536.53%-70.56M | -311.45%-140.57M | -320.18%-81.64M | -92.85%-31.53M |
| Less:Minority Profit | 80.56%-3.12M | 99.41%-83.2K | 99.11%-64.21K | -99.92%-26.31M | -58.09%-16.04M | -164.79%-14.06M | -271.28%-7.25M | -1,921.50%-13.16M | -1,019.81%-10.14M | -810.22%-5.31M |
| Net profit of parent company owners | 63.93%-70.64M | 77.08%-36.04M | 76.87%-14.64M | -173.61%-348.59M | -173.91%-195.83M | -499.55%-157.22M | -593.29%-63.31M | -265.19%-127.4M | -248.20%-71.49M | -53.37%-26.22M |
| Earning per share | ||||||||||
| Basic earning per share | 63.93%-0.4435 | 77.07%-0.2263 | 76.88%-0.0919 | -173.45%-2.1887 | -173.53%-1.2295 | -498.61%-0.9871 | -591.30%-0.3975 | -242.78%-0.8004 | -221.07%-0.4495 | -35.05%-0.1649 |
| Diluted earning per share | 63.93%-0.4435 | 77.07%-0.2263 | 76.88%-0.0919 | -173.45%-2.1887 | -173.53%-1.2295 | -498.61%-0.9871 | -591.30%-0.3975 | -242.78%-0.8004 | -221.07%-0.4495 | -35.05%-0.1649 |
| Other composite income | ||||||||||
| Total composite income | 65.19%-73.76M | 78.91%-36.12M | 79.16%-14.71M | -166.71%-374.9M | -159.52%-211.86M | -443.19%-171.27M | -536.53%-70.56M | -311.45%-140.57M | -320.18%-81.64M | -92.85%-31.53M |
| Total composite income of parent company owners | 63.93%-70.64M | 77.08%-36.04M | 76.87%-14.64M | -173.61%-348.59M | -173.91%-195.83M | -499.55%-157.22M | -593.29%-63.31M | -265.19%-127.4M | -248.20%-71.49M | -53.37%-26.22M |
| Total composite income of minority owners | 80.56%-3.12M | 99.41%-83.2K | 99.11%-64.21K | -99.92%-26.31M | -58.09%-16.04M | -164.79%-14.06M | -271.28%-7.25M | -1,921.50%-13.16M | -1,019.81%-10.14M | -810.22%-5.31M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data